Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $1.78 million
- Book Value:
- Revenue TTM:
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Univec Inc had its IPO on 1997-04-24 under the ticker symbol UNVC.
The company operates in the Healthcare sector and Medical Care Facilities industry. Univec Inc has a staff strength of 0 employees.
Shares of Univec Inc opened at $0.01 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.01 - $0.01, and closed at $0.01.
This is a -2.97% slip from the previous day's closing price.
A total volume of 89,822 shares were traded at the close of the day’s session.
In the last one week, shares of Univec Inc have increased by +3.16%.
Univec Inc's Key Ratios
Univec Inc has a market cap of $1.78 million, indicating a price to book ratio of 0 and a price to sales ratio of 69.6256.
In the last 12-months Univec Inc’s revenue was $28629 with a gross profit of $-10887 and an EBITDA of $-332551. The EBITDA ratio measures Univec Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Univec Inc’s operating margin was -1709.52% while its return on assets stood at -43.76% with a return of equity of 0%.
In Q2, Univec Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Univec Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-0.24 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Univec Inc’s profitability.
Univec Inc stock is trading at a EV to sales ratio of 44.0195 and a EV to EBITDA ratio of -3.9815. Its price to sales ratio in the trailing 12-months stood at 69.6256.
Univec Inc stock pays annual dividends of $0 per share, indicating a yield of 0.91% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- Total Liabilities
- $3.13 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Univec Inc ended 2023 with $15948.00 in total assets and $0 in total liabilities. Its intangible assets were valued at $15948.00 while shareholder equity stood at $-3250943.00.
Univec Inc ended 2023 with $0 in deferred long-term liabilities, $3.13 million in other current liabilities, 181210.00 in common stock, $-17748586.00 in retained earnings and $0 in goodwill. Its cash balance stood at $15480.00 and cash and short-term investments were $0. The company’s total short-term debt was $1,194,850 while long-term debt stood at $133603.00.
Univec Inc’s total current assets stands at $15948.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $468.00 compared to accounts payable of $1138.00 and inventory worth $0.
In 2023, Univec Inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Univec Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Univec Inc stock is currently trading at $0.01 per share. It touched a 52-week high of $0.025 and a 52-week low of $0.025. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.01 and 200-day moving average was $0.01 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Univec Inc
Similar Industry Stocks (Medical Care Facilities)
Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers 1 cc AD-syringe for aspirating and non-aspirating applications, which are used for dispensing dosages of allergy, immunization, and insulin medicines. It also manufactures and markets sliding sheath syringes that are designed to protect patients and healthcare workers from needle stick injuries; and bifurcated needle safety syringes, which are used in administering smallpox vaccines in response to bio-terrorist threats. Univec markets its auto-disable syringes and sliding sheath safety syringes to private hospitals, health facilities, and distributors in the United States, as well as to governments of developing countries. In addition, it assists pharmaceutical companies in marketing, fulfillment, and tracking drug samples via an online system connecting pharmacies and managed payment providers. The company was founded in 1992 and is based in Baltimore, Maryland.